Stung By COVID Critics, EU Looks To BARDA-Style Agency To Act Faster On Variants
HERA Incubator To Be Launched
Executive Summary
The European Commission wants to learn from mistakes made in the COVID-19 crisis and to create an end-to-end system to co-ordinate funding, clinical research and manufacturing of vaccines.
You may also be interested in...
EU’s New Health Threats Body Could Speed Arrival Of New Antibiotics
Europe is preparing a “preparatory action” to review existing measures for tackling antimicrobial resistance, identify the gaps, and to determine what products will be needed in future.
EU To Boost Portfolio Of Potential COVID-19 Treatments
The European Commission has set up a new expert group on virus variants whose tasks will include selecting the criteria for identifying possible new treatments and vaccines for COVID-19.
EU Explains Plans To Speed Up Variant Vaccine Approvals
The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.